Is PBIO or DVY a better dividend investment in 2026?

PBIO currently yields 166666.67% with a 5% 5-year dividend growth rate. DVY yields 3.50% with 5% growth. The better choice depends on your goal: PBIO offers higher current income.

What is the dividend yield difference between PBIO and DVY?

PBIO has a forward dividend yield of 166666.67% ($2.00/share annually). DVY yields 3.50% ($5.25/share annually). The yield gap is 166663.17 percentage points.

Home › Compare › PBIO vs DVY

PBIO vs DVY: Dividend Comparison 2026

PBIO yields 166666.67% · DVY yields 3.50%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PBIO wins by $11911377672882.59M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PBIO

● Live price

166666.67%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$11911377672882.62M

Annual income

$5,393,136,696,480,418,000.00

Full PBIO calculator →

DVY

● Live price

3.50%

Share price

$150.03

Annual div

$5.25

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.1K

Annual income

$437.78

Full DVY calculator →

Portfolio growth — PBIO vs DVY

📍 PBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PBIO	DVY
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PBIO + DVY cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PBIO pays

DVY pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PBIO

Annual income on $10K today (after 15% tax)

$14,166,666.67/yr

After 10yr DRIP, annual income (after tax)

$4,584,166,192,008,355,000.00/yr

DVY

Annual income on $10K today (after 15% tax)

$297.17/yr

After 10yr DRIP, annual income (after tax)

$372.11/yr

At 15% tax rate, PBIO beats the other by $4,584,166,192,008,354,300.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PBIO + DVY for your $10,000?

PBIO: 50%DVY: 50%

100% DVY50/50100% PBIO

Portfolio after 10yr

$5955688836441.32M

Annual income

$2,696,568,348,240,209,000.00/yr

Blended yield

45.28%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on PBIO right now

PBIO

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-50.4

Piotroski

2/9

DVY

No analyst data

Altman Z

307.5

Piotroski

1/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PBIO buys

DVY buys

No recent congressional trades found for PBIO or DVY in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPBIODVY

Forward yield	166666.67% ✓	3.50%
Annual dividend / share	$2.00	$5.25 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	-50%	0% ✓
Portfolio after 10y	$11911377672882.62M ✓	$25.1K
Annual income after 10y	$5,393,136,696,480,418,000.00 ✓	$437.78
Total dividends collected	$11310008644767.18M ✓	$4.0K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: PBIO vs DVY ($10,000, DRIP)

Year	PBIO Portfolio	PBIO Income/yr	DVY Portfolio	DVY Income/yr	Gap
1← crossover	$8,344,033	$8,333,333.33	$11,050	$349.62	+$8.33M → PBIO
2	$3,258,162,280	$3,249,234,164.07	$12,184	$361.04	+$3258.15M → PBIO
3	$596,362,299,915	$592,876,066,275.31	$13,409	$372.07	+$596362.29M → PBIO
4	$51,347,407,585,706	$50,709,299,924,797.41	$14,730	$382.68	+$51347407.57M → PBIO
5	$2,095,186,069,772,327	$2,040,244,343,655,621.00	$16,154	$392.89	+$2095186069.76M → PBIO
6	$41,143,898,865,343,200	$38,902,049,770,686,810.00	$17,688	$402.69	+$41143898865.33M → PBIO
7	$401,002,058,588,188,860	$356,978,086,802,271,700.00	$19,338	$412.07	+$401002058588.17M → PBIO
8	$2,054,879,028,737,436,700	$1,625,806,826,048,074,500.00	$21,113	$421.04	+$2054879028737.42M → PBIO
9	$6,091,813,996,637,570,000	$3,893,093,435,888,512,500.00	$23,020	$429.61	+$6091813996637.55M → PBIO
10	$11,911,377,672,882,618,000	$5,393,136,696,480,418,000.00	$25,070	$437.78	+$11911377672882.59M → PBIO

PBIO vs DVY: Complete Analysis 2026

PBIO — Stock

Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was incorporated in 1978 and is based in South Easton, Massachusetts. As of August 2, 2022, Pressure BioSciences, Inc. operates as a subsidiary of Emergent Health Corp.

Full PBIO Calculator →

DVY — ETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →

📬

Get this PBIO vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PBIO vs SCHD PBIO vs JEPI PBIO vs O PBIO vs KO PBIO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.